Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

G Mazzaglia; Sabine Straus; P Arlett; D de Silva; H Janssen; J Raine; E Alteri

doi:10.1007/s40264-017-0604-4

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

G Mazzaglia, Sabine Straus, P Arlett, D de Silva, H Janssen, J Raine, E Alteri

Medical Informatics

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

8 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	191-202
Number of pages	12
Journal	Drug Safety
Volume	41
Issue number	2
DOIs	https://doi.org/10.1007/s40264-017-0604-4
Publication status	Published - 2018

Research programs

EMC NIHES-03-77-02

Access to Document

10.1007/s40264-017-0604-4

REPUB_102863-OA.pdfFinal published version, 517 KB

http://hdl.handle.net/1765/102863

Cite this

@article{79312252bf81458393cd6093c0f09a31,

title = "Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs",

author = "G Mazzaglia and Sabine Straus and P Arlett and {de Silva}, D and H Janssen and J Raine and E Alteri",

year = "2018",

doi = "10.1007/s40264-017-0604-4",

language = "Undefined/Unknown",

volume = "41",

pages = "191--202",

journal = "Drug Safety",

issn = "0114-5916",

publisher = "Adis",

number = "2",

}

TY - JOUR

T1 - Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

AU - Mazzaglia, G

AU - Straus, Sabine

AU - Arlett, P

AU - de Silva, D

AU - Janssen, H

AU - Raine, J

AU - Alteri, E

PY - 2018

Y1 - 2018

U2 - 10.1007/s40264-017-0604-4

DO - 10.1007/s40264-017-0604-4

M3 - Article

C2 - 29124666

SN - 0114-5916

VL - 41

SP - 191

EP - 202

JO - Drug Safety

JF - Drug Safety

IS - 2

ER -